Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 82 Lymphoid 11 Sarcoma 7 Other hematologic neoplasm 4 Thoracic 2 Dermatologic 2 Plasma cell 1 Other solid neoplasm 1 Genitourinary 1 Gastrointestinal 1 Breast 1

Conditions

Interventions

Cisplatin 147 pembrolizumab 129 Carboplatin 125 Injections 108 Pemetrexed 99 Paclitaxel 97 Gemcitabine 85 Irinotecan 75 Cyclophosphamide 72 Nivolumab 71 Docetaxel 68 Bevacizumab 59 Oxaliplatin 50 Fluorouracil 50 Capecitabine 48 atezolizumab 46 Leucovorin 42 Etoposide 42 tislelizumab 40 toripalimab 36 fludarabine 32 Drug Therapy 32 Ipilimumab 30 Topotecan 29 durvalumab 28 Vincristine 27 Early Intervention, Educational 27 Specimen Handling 26 Radiotherapy 26 Interviews as Topic 25

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Lomustine × Other solid neoplasm × Clear all

NCT05898451 2023-06-12

R-2

Refnot-Pharm Ltd

Phase 2 Completed

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡